Oklahoma U.S. Rep Markwayne Mullin: “Energy is the backbone of any economy. The U.S. paid Russia $17.5 BILLION for petroleum imports in…”

Oklahoma U.S. Rep Markwayne Mullin: “Energy is the backbone of any economy. The U.S. paid Russia .5 BILLION for petroleum imports in…”
0Comments

Markwayne Mullin tweeted the following:

“Energy is the backbone of any economy. The U.S. paid Russia $17.5 BILLION for petroleum imports in 2021 alone. If President Biden was serious about his economic sanctions, hed stop these imports immediately.”
Read on Twitter

Here are other recent tweets from Markwayne Mullin:

“Try as he might, the President cannot rewrite the past year. The American people are smarter than that. Americans are paying more for just about everything and their constitutional freedoms are under attack. They will not forget who caused it.
Read here: mullin.house.gov/news/documents
Read on Twitter
“Increased regulation stifles American innovation. The Biden Administration needs to get out of the way.” on March 2
Read on Twitter
“Thank you @TheHillEvents for including me in this important conversation. twitter.com/TheHillEvents/” on March 2
Read on Twitter



Related

Benjamin D. Moncarz Chief Financial Officer - FDA

How many companies in cities in Pittsburg County received FDA inspections in 2025?

There was one company in a city associated with Pittsburg County that received an FDA inspection in 2025, according to the U.S. Food and Drug Administration.

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

Bryan County cities: 2 companies received FDA inspections in 2025

There were two companies in cities associated with Bryan County that received two FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Sean R. Keveney J.D., Chief Counsel of FDA

How many FDA citations were issued in cities within McCurtain County in Q1

There was one company in a city associated with McCurtain County that received FDA citations as a result of one inspection conducted in the county over the first quarter of 2026, according to reports from the U.S. Food and Drug Administration (FDA).